NUMIF Numinus Wellness Inc.Stock Price & Overview
$0.130.0001 (+0.08%)10:34 AM 09/27/23
OTCQX | $USD | Delayed
Charts
FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close
Quant Ranking
Ratings Summary
| Now | 6M ago | |
|---|---|---|
SA Analysts | Not CoveredRating: Not Covered | |
Wall Street | Not CoveredRating: Not Covered | |
Quant | Not CoveredRating: Not Covered | |
Ratings Summary
SA Analysts
Wall Street
Quant
| Now | 3M ago | 6M ago | |
|---|---|---|---|
Valuation | -Rating: Not Covered | ||
Growth | -Rating: Not Covered | ||
Profitability | -Rating: Not Covered | ||
Momentum | -Rating: Not Covered | ||
Revisions | -Rating: Not Covered | ||
See NUMIF ratings with Premium.
Company Profile
Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health. The company operates through three segments: Research Operations, Canadian Clinic Network, and U.S Clinic Network. The Research Operations segment offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics. The Canadian Clinic Network segment provides supportive therapies and technologies to focus on treating mental health and substance abuse; and services for KAP, psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This segments also offers training, facilities, and other operational resources to practitioners. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.